Skip to main navigation Skip to search Skip to main content

States Trial - A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Eficacy Study of Staccato Alprazolam (STAP-001) in Subjects with Epilepsy with a Predictable Seizure Pattern

Project: Research

Project Details

StatusFinished
Effective start/end date01/2/19 → 01/2/21

Funding

  • Engage Therapeutics Incorporated: $14,340.00